Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The daily Top 10 COVID papers


  Free Subscription


1 Acta Haematol
1 Am J Clin Pathol
6 Ann Hematol
2 BMC Cancer
12 Br J Haematol
2 Cancer
2 Cancer Res
1 Eur J Haematol
1 Exp Cell Res
1 Exp Hematol
1 Genes Chromosomes Cancer
1 Int J Hematol
4 J Clin Oncol
1 J Pediatr Hematol Oncol
3 Leuk Lymphoma
4 Leukemia
1 PLoS One

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Acta Haematol

  1. MAITI A, Franquiz MJ, Ravandi F, Cortes JE, et al
    Venetoclax and BCR-ABL Tyrosine Kinase Inhibitor Combinations: Outcome in Patients with Philadelphia Chromosome-Positive Advanced Myeloid Leukemias.
    Acta Haematol. 2020;143:567-573.
    PubMed         Abstract available

    Am J Clin Pathol

  2. HORNA P, Olteanu H, Jevremovic D, Otteson GE, et al
    Single-Antibody Evaluation of T-Cell Receptor beta Constant Chain Monotypia by Flow Cytometry Facilitates the Diagnosis of T-Cell Large Granular Lymphocytic Leukemia.
    Am J Clin Pathol. 2021 Jan 13. pii: 6092418. doi: 10.1093.
    PubMed         Abstract available

    Ann Hematol

  3. AMIT O, On YB, Perez G, Shargian-Alon L, et al
    Venetoclax and donor lymphocyte infusion for early relapsed acute myeloid leukemia after allogeneic hematopoietic cell transplantation. A retrospective multicenter trial.
    Ann Hematol. 2021 Jan 13. pii: 10.1007/s00277-021-04398.
    PubMed         Abstract available

  4. MARTIN-MORO F, Garcia-Cosio M, Marquet-Palomanes J, Lopez-Gutierrez M, et al
    Intracranial hemorrhage as presentation of chronic lymphocytic leukemia successfully treated with ibrutinib.
    Ann Hematol. 2021 Jan 9. pii: 10.1007/s00277-021-04393.

  5. KERUAKOUS AR, Balakrishna P, Schmidt SA, Autry MT, et al
    Genomic profiling is a supplemental diagnostic and therapeutic modality for hairy cell leukemia variant.
    Ann Hematol. 2021 Jan 12. pii: 10.1007/s00277-021-04408.

  6. SCHLAWECK S, Brossart P, Heine A
    Vemurafenib as bridging therapy of hairy cell leukemia in a Jehovah's Witness patient.
    Ann Hematol. 2021 Jan 12. pii: 10.1007/s00277-021-04403.

  7. LIAO PW, Wang RC, Chen TC, Teng CJ, et al
    Venetoclax-induced panniculitis in an acute myeloid leukemia patient.
    Ann Hematol. 2021 Jan 13. pii: 10.1007/s00277-020-04372.

  8. VOIGT M, Sinn K, Malouhi A, Gecks T, et al
    HHV-6 encephalitis in a non-transplanted adult acute myeloid leukemia patient.
    Ann Hematol. 2021 Jan 14. pii: 10.1007/s00277-021-04409.

    BMC Cancer

  9. LI XY, Li JQ, Luo XQ, Wu XD, et al
    Reduced intensity of early intensification does not increase the risk of relapse in children with standard risk acute lymphoblastic leukemia - a multi-centric clinical study of GD-2008-ALL protocol.
    BMC Cancer. 2021;21:59.
    PubMed         Abstract available

  10. MOHAMMADZADEH Z, Omidkhoda A, Chahardouli B, Hoseinzadeh G, et al
    The impact of ICAM-1, CCL2 and TGM2 gene polymorphisms on differentiation syndrome in acute promyelocytic leukemia.
    BMC Cancer. 2021;21:46.
    PubMed         Abstract available

    Br J Haematol

  11. JIANG Y, Li Y, Cheng J, Ma J, et al
    Upregulation of AKR1C1 in mesenchymal stromal cells promotes the survival of acute myeloid leukaemia cells.
    Br J Haematol. 2020;189:694-706.
    PubMed         Abstract available

  12. CHEN X, Chen H
    BCR-ABL1-positive acute myeloid leukaemia relapsing as acute lymphoblastic leukaemia.
    Br J Haematol. 2020;189:591.

  13. CICIARELLO M, Curti A
    Good news for acute myeloid leukaemia patients from the stroll niche?
    Br J Haematol. 2020;189:597-599.

  14. MIKLOS U, Strugov V, Lewerin C, Grosicki S, et al
    Five-year survival follow-up of a phase III randomised trial comparing ofatumumab versus physicians' choice for bulky fludarabine-refractory chronic lymphocytic leukaemia: a short report.
    Br J Haematol. 2020;189:689-693.
    PubMed         Abstract available

  15. UDEN T, Bertaina A, Abrahamsson J, Ansari M, et al
    Outcome of children relapsing after first allogeneic haematopoietic stem cell transplantation for acute myeloid leukaemia: a retrospective I-BFM analysis of 333 children.
    Br J Haematol. 2020;189:745-750.
    PubMed         Abstract available

  16. ONECHA E, Ruiz-Heredia Y, Martinez-Cuadron D, Barragan E, et al
    Improving the prediction of acute myeloid leukaemia outcomes by complementing mutational profiling with ex vivo chemosensitivity.
    Br J Haematol. 2020;189:672-683.
    PubMed         Abstract available

  17. PRIETO-CONDE MI, Jimenez C, Garcia-Alvarez M, Ramos F, et al
    Identification of relapse-associated gene mutations by next-generation sequencing in low-risk acute myeloid leukaemia patients.
    Br J Haematol. 2020;189:718-730.
    PubMed         Abstract available

  18. ROBINSON SE, Harrison CN
    How we manage Philadelphia-negative myeloproliferative neoplasms in pregnancy.
    Br J Haematol. 2020;189:625-634.
    PubMed         Abstract available

  19. GIUSTI GNN, Jotta PY, Lopes CO, Ganazza MA, et al
    Test trial of spike-in immunoglobulin heavy-chain (IGH) controls for next generation sequencing quantification of minimal residual disease in acute lymphoblastic leukaemia.
    Br J Haematol. 2020;189:e150-e154.

  20. INABA H, Cao X, Chang JY, Karol SE, et al
    Incidence of hip and knee osteonecrosis and their associations with bone mineral density in children with acute lymphoblastic leukaemia.
    Br J Haematol. 2020;189:e177-e181.

  21. ADELAIDE J, Cervera N, Guille A, Murati A, et al
    Gains of EPOR and ERG genes in adult erythroleukaemia.
    Br J Haematol. 2020;189:e174-e177.

  22. RAYMOND LM, Funk T, Braziel RM, Fan G, et al
    Mast cell sarcoma with concurrent mast cell leukaemia.
    Br J Haematol. 2020;189:e160-e164.


  23. ORAN B, Garcia-Manero G, Saliba RM, Alfayez M, et al
    Posttransplantation cyclophosphamide improves transplantation outcomes in patients with AML/MDS who are treated with checkpoint inhibitors.
    Cancer. 2020;126:2193-2205.
    PubMed         Abstract available

  24. ABOU DALLE I, Kantarjian HM, Ravandi F, Daver N, et al
    Phase 2 study of lenalidomide maintenance for patients with high-risk acute myeloid leukemia in remission.
    Cancer. 2021 Jan 15. doi: 10.1002/cncr.33409.
    PubMed         Abstract available

    Cancer Res

  25. STIEHL T, Wang W, Lutz C, Marciniak-Czochra A, et al
    Mathematical Modeling Provides Evidence for Niche Competition in Human AML and Serves as a Tool to Improve Risk Stratification.
    Cancer Res. 2020;80:3983-3992.
    PubMed         Abstract available

  26. TOHUMEKEN S, Baur R, Bottcher M, Stoll A, et al
    Palmitoylated Proteins on AML-Derived Extracellular Vesicles Promote Myeloid-Derived Suppressor Cell Differentiation via TLR2/Akt/mTOR Signaling.
    Cancer Res. 2020;80:3663-3676.
    PubMed         Abstract available

    Eur J Haematol

  27. GEISSLER K, Jager E, Barna A, Graf T, et al
    Myelomonocytic skewing in chronic myelomonocytic leukemia: phenotypic, molecular and biologic features and impact on survival.
    Eur J Haematol. 2021 Jan 12. doi: 10.1111/ejh.13577.
    PubMed         Abstract available

    Exp Cell Res

  28. WANG C, Li L, Li M, Shen X, et al
    Corrigendum to "Inactivated STAT5 pathway underlies a novel inhibitory role of EBF1 in chronic lymphocytic leukemia" [Exp. Cell Res. 398(1) 112371].
    Exp Cell Res. 2021 Jan 8:112469. doi: 10.1016/j.yexcr.2020.112469.

    Exp Hematol

  29. FITCH B, Roy R, Geng H, Montecino-Rodriguez E, et al
    Human pediatric B-cell acute lymphoblastic leukemias can be classified as B-1 or B-2-like based on a minimal transcriptional signature.
    Exp Hematol. 2020;90:65-71.
    PubMed         Abstract available

    Genes Chromosomes Cancer

  30. ORSMARK-PIETRAS C, Landberg N, Lorenz F, Uggla B, et al
    Clinical and genomic characterization of patients diagnosed with the provisional entity Acute myeloid leukemia with BCR-ABL1, a Swedish population-based study.
    Genes Chromosomes Cancer. 2021 Jan 12. doi: 10.1002/gcc.22936.
    PubMed         Abstract available

    Int J Hematol

  31. SAKAMOTO H, Itonaga H, Sawayama Y, Kojima A, et al
    Allogeneic hematopoietic stem cell transplantation for adult T-cell leukemia/lymphoma with HTLV-1-associated myelopathy.
    Int J Hematol. 2021 Jan 10. pii: 10.1007/s12185-020-03075.
    PubMed         Abstract available

    J Clin Oncol

  32. KHALDOYANIDI S, Nagorsen D, Stein A, Ossenkoppele G, et al
    Immune Biology of Acute Myeloid Leukemia: Implications for Immunotherapy.
    J Clin Oncol. 2021 Jan 12:JCO2000475. doi: 10.1200/JCO.20.00475.

  33. O'NEILL AT, Chakraverty R
    Graft Versus Leukemia: Current Status and Future Perspectives.
    J Clin Oncol. 2021 Jan 12:JCO2001801. doi: 10.1200/JCO.20.01801.
    PubMed         Abstract available

  34. LUSSANA F, Gritti G, Rambaldi A
    Immunotherapy of Acute Lymphoblastic Leukemia and Lymphoma With T Cell-Redirected Bispecific Antibodies.
    J Clin Oncol. 2021 Jan 12:JCO2001564. doi: 10.1200/JCO.20.01564.

  35. AGRAWAL AK, Michlitsch J, Golden C, Hastings CA, et al
    Nelarabine in Pediatric and Young Adult T-Cell Acute Lymphoblastic Leukemia-Clearly Beneficial?
    J Clin Oncol. 2021 Jan 14:JCO2002973. doi: 10.1200/JCO.20.02973.

    J Pediatr Hematol Oncol

  36. OBEROI S, Dawson A, Marko D, Almiski M, et al
    Precursor B-Cell Acute Lymphoblastic Leukemia With MYC and BCL2 Rearrangements Presenting as Extensive Extranodal Disease in an Adolescent.
    J Pediatr Hematol Oncol. 2021 Jan 11. pii: 00043426-900000000-97026.
    PubMed         Abstract available

    Leuk Lymphoma

  37. GHIA P, Dlugosz-Danecka M, Scarfo L, Jurczak W, et al
    Acalabrutinib: a highly selective, potent Bruton tyrosine kinase inhibitor for the treatment of chronic lymphocytic leukemia.
    Leuk Lymphoma. 2021 Jan 11:1-18. doi: 10.1080/10428194.2020.1864352.
    PubMed         Abstract available

  38. LI SY, Lu Y, Liu HC, Gang EJ, et al
    Arsenic trioxide and all-trans retinoic acid in the treatment of children with newly diagnosed acute promyelocytic leukemia.
    Leuk Lymphoma. 2021 Jan 13:1-6. doi: 10.1080/10428194.2020.1856832.

  39. GARCIA-HORTON A, Maze D, McNamara CJ, Sibai H, et al
    Azacitidine and venetoclax for the treatment of accelerated and blast phase myeloproliferative neoplasms and chronic myelomonocytic leukemia: a case series.
    Leuk Lymphoma. 2021 Jan 15:1-6. doi: 10.1080/10428194.2020.1869961.


  40. O'NIONS J, Muir L, Zheng J, Rees-Spear C, et al
    SARS-CoV-2 antibody responses in patients with acute leukaemia.
    Leukemia. 2021;35:289-292.

  41. SWOBODA DM, Ali NA, Chan O, Padron E, et al
    PTPN11 mutations are associated with poor outcomes across myeloid malignancies.
    Leukemia. 2021;35:286-288.

  42. NOFRINI V, Matteucci C, Pellanera F, Gorello P, et al
    Activating somatic and germline TERT promoter variants in myeloid malignancies.
    Leukemia. 2021;35:274-278.

  43. NAGATE Y, Ezoe S, Fujita J, Okuzaki D, et al
    Ectonucleotidase CD39 is highly expressed on ATLL cells and is responsible for their immunosuppressive function.
    Leukemia. 2021;35:107-118.
    PubMed         Abstract available

    PLoS One

  44. MASHIMA K, Oh I, Fujiwara K, Izawa J, et al
    Comparison of alemtuzumab, anti-thymocyte globulin, and post-transplant cyclophosphamide for graft-versus-host disease and graft-versus-leukemia in murine models.
    PLoS One. 2021;16:e0245232.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Leukemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.